Literature DB >> 21690289

The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain.

Elke Burgermeister1, Teresa Friedrich, Ivana Hitkova, Ivonne Regel, Henrik Einwächter, Wolfgang Zimmermann, Christoph Röcken, Aurel Perren, Matthew B Wright, Roland M Schmid, Rony Seger, Matthias P A Ebert.   

Abstract

Peroxisome proliferator-activated receptor γ (PPARγ) is a transcription factor that promotes differentiation and cell survival in the stomach. PPARγ upregulates and interacts with caveolin-1 (Cav1), a scaffold protein of Ras/mitogen-activated protein kinases (MAPKs). The cytoplasmic-to-nuclear localization of PPARγ is altered in gastric cancer (GC) patients, suggesting a so-far-unknown role for Cav1 in spatial regulation of PPARγ signaling. We show here that loss of Cav1 accelerated proliferation of normal stomach and GC cells in vitro and in vivo. Downregulation of Cav1 increased Ras/MAPK-dependent phosphorylation of serine 84 in PPARγ and enhanced nuclear translocation and ligand-independent transcription of PPARγ target genes. In contrast, Cav1 overexpression sequestered PPARγ in the cytosol through interaction of the Cav1 scaffolding domain (CSD) with a conserved hydrophobic motif in helix 7 of PPARγ's ligand-binding domain. Cav1 cooperated with the endogenous Ras/MAPK inhibitor docking protein 1 (Dok1) to promote the ligand-dependent transcriptional activity of PPARγ and to inhibit cell proliferation. Ligand-activated PPARγ also reduced tumor growth and upregulated the Ras/MAPK inhibitors Cav1 and Dok1 in a murine model of GC. These results suggest a novel mechanism of PPARγ regulation by which Ras/MAPK inhibitors act as scaffold proteins that sequester and sensitize PPARγ to ligands, limiting proliferation of gastric epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690289      PMCID: PMC3147789          DOI: 10.1128/MCB.01421-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

Review 1.  The multiple faces of caveolae.

Authors:  Robert G Parton; Kai Simons
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 2.  Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator.

Authors:  Olivier van Beekum; Veerle Fleskens; Eric Kalkhoven
Journal:  Obesity (Silver Spring)       Date:  2009-02       Impact factor: 5.002

Review 3.  The roles of Dok family adapters in immunoreceptor signaling.

Authors:  Ryuichi Mashima; Yukihiro Hishida; Tohru Tezuka; Yuji Yamanashi
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

4.  Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

Authors:  Babak Razani; Terry P Combs; Xiao Bo Wang; Philippe G Frank; David S Park; Robert G Russell; Maomi Li; Baiyu Tang; Linda A Jelicks; Philipp E Scherer; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

5.  Peroxisome proliferator-activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumour cells.

Authors:  M Azharul Karim Rumi; Shunji Ishihara; Yasunori Kadowaki; C F Ortega-Cava; Hideaki Kazumori; Kousaku Kawashima; Nagisa Yoshino; Takafumi Yuki; Norihisa Ishimura; Yoshikazu Kinoshita
Journal:  Genes Cells       Date:  2004-11       Impact factor: 1.891

6.  A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages.

Authors:  Annie Demers; Véronique Caron; Amélie Rodrigue-Way; Walter Wahli; Huy Ong; André Tremblay
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

7.  Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.

Authors:  Gemma Llaverias; Manuel Vázquez-Carrera; Rosa M Sánchez; Véronique Noé; Carlos J Ciudad; Juan C Laguna; Marta Alegret
Journal:  J Lipid Res       Date:  2004-08-16       Impact factor: 5.922

8.  Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.

Authors:  Jean Philippe Gratton; Michelle I Lin; Jun Yu; Erik D Weiss; Zao Li Jiang; Todd A Fairchild; Yasuko Iwakiri; Roberto Groszmann; Kevin P Claffey; Yung Chi Cheng; William C Sessa
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

Review 9.  Control of gut differentiation and intestinal-type gastric carcinogenesis.

Authors:  Yasuhito Yuasa
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

10.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

Authors:  Denise Kelly; Jamie I Campbell; Timothy P King; George Grant; Emmelie A Jansson; Alistair G P Coutts; Sven Pettersson; Shaun Conway
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

View more
  22 in total

1.  Structure-based reassessment of the caveolin signaling model: do caveolae regulate signaling through caveolin-protein interactions?

Authors:  Brett M Collins; Melissa J Davis; John F Hancock; Robert G Parton
Journal:  Dev Cell       Date:  2012-07-17       Impact factor: 12.270

2.  Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding protein.

Authors:  Elke Prade; Moritz Tobiasch; Ivana Hitkova; Isabell Schäffer; Fan Lian; Xiangbin Xing; Marc Tänzer; Sandra Rauser; Axel Walch; Marcus Feith; Stefan Post; Christoph Röcken; Roland M Schmid; Matthias P A Ebert; Elke Burgermeister
Journal:  Mol Endocrinol       Date:  2012-04-03

Review 3.  Minireview: Challenges and opportunities in development of PPAR agonists.

Authors:  Matthew B Wright; Michele Bortolini; Moh Tadayyon; Martin Bopst
Journal:  Mol Endocrinol       Date:  2014-08-22

4.  Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.

Authors:  Tong Li; Beifang Li; Asgharpour Sara; Christine Ay; Wing Yan Leung; Yanquan Zhang; Yujuan Dong; Qiaoyi Liang; Xiang Zhang; Philip Weidner; Tobias Gutting; Hans-Michael Behrens; Christoph Röcken; Joseph Jy Sung; Matthias P Ebert; Jun Yu; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2019-08-21       Impact factor: 8.110

5.  Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism.

Authors:  Kai Yang; Wenju Lu; Qian Jiang; Xin Yun; Mingming Zhao; Haiyang Jiang; Jian Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

6.  Ha-RasV12-Induced Multilayer Cellular Aggregates Is Mediated by Rac1 Activation Rather Than YAP Activation.

Authors:  Li-Ying Wu; Chia-Lin Han; Hsi-Hui Lin; Ming-Jer Tang
Journal:  Biomedicines       Date:  2022-04-23

7.  Inactivation of the Ras/MAPK/PPARγ signaling axis alleviates diabetic mellitus-induced erectile dysfunction through suppression of corpus cavernosal endothelial cell apoptosis by inhibiting HMGCS2 expression.

Authors:  Zhuo Zhang; Hai-Yan Zhang; Ying Zhang; Hai Li
Journal:  Endocrine       Date:  2018-11-20       Impact factor: 3.633

8.  The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis.

Authors:  Jong-Min Lee; Sung Soo Kim; Young-Seok Cho
Journal:  PPAR Res       Date:  2012-08-09       Impact factor: 4.964

9.  Evaluating caveolin interactions: do proteins interact with the caveolin scaffolding domain through a widespread aromatic residue-rich motif?

Authors:  Dominic P Byrne; Caroline Dart; Daniel J Rigden
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

10.  Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis.

Authors:  Ivana Hitkova; Gang Yuan; Florian Anderl; Markus Gerhard; Thomas Kirchner; Simone Reu; Christoph Röcken; Claus Schäfer; Roland M Schmid; Roger Vogelmann; Matthias P A Ebert; Elke Burgermeister
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.